Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha 1-blocker combination therapy for hypertension

M C Houston1

  • 1Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

Postgraduate Medicine
|September 22, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Juice powder concentrate and systemic blood pressure, progression of coronary artery calcium and antioxidant status in hypertensive subjects: a pilot study.

Evidence-based complementary and alternative medicine : eCAM·2008
Same author

A free-ranging roundtable discussion on hypertension.

Journal of human hypertension·2005
Same author

Postoperative morbidity in the morbidly obese parturient woman: supraumbilical and low transverse abdominal approaches.

American journal of obstetrics and gynecology·2000
Same author

The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil.

Archives of internal medicine·1995
Same author

Hypertension and coronary heart disease risk factor management.

Australian family physician·1994
Same author

Hypertension and coronary heart disease risk factor management.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·1993
Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
Same journal

Risk of adverse effects of the concomitant use of statins with calcium channel blockers: a systematic review and meta-analysis.

Postgraduate medicine·2026
Same journal

Association between frailty and major chronic disease-free life expectancy: a large community-based longitudinal study.

Postgraduate medicine·2026
See all related articles

Combination therapy offers improved tolerability and efficacy for hypertension. Alpha-1 blockers are a suitable choice for combination regimens, potentially improving metabolic profiles and counteracting adverse effects of other drugs.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Nephrology

Background:

  • Hypertension management often requires combination therapy for severe or resistant cases.
  • Combination therapy aims for improved tolerability and enhanced antihypertensive efficacy.
  • Long-term studies are needed to compare end-organ damage reduction with newer versus older antihypertensive agents.

Purpose of the Study:

  • To evaluate the role and benefits of combination therapy in hypertension management.
  • To highlight the advantages of alpha-1 blockers in combination regimens.
  • To assess the impact of alpha-1 blockers on metabolic parameters and comorbidities.

Main Methods:

  • Review of scientific evidence on combination antihypertensive therapy.
  • Analysis of the properties and interactions of alpha-1 blockers within combination regimens.

Related Experiment Videos

  • Evaluation of effects on end-organ damage, metabolic profiles, and coexisting conditions.

    • Main Results:

    • Combination therapy is cost-effective and rational for severe or resistant hypertension.
    • Alpha-1 blockers are suitable for combination therapy, acting additively or synergistically with most agents.
    • Alpha-1 blockers may improve lipid, glucose, and insulin levels, counteract adverse effects of other drugs, and potentially regress left ventricular hypertrophy (LVH).

    Conclusions:

    • Combination therapy, particularly with alpha-1 blockers, offers significant advantages in hypertension management.
    • Alpha-1 blockers present a favorable profile regarding metabolic effects and comorbidities.
    • Further prospective studies are warranted to confirm long-term benefits on end-organ damage reduction.